Literature DB >> 27418761

The effect of N-acetylcysteine on oxidative serum biomarkers of hemodialysis patients.

I Giannikouris1.   

Abstract

BACKGROUND: The aim of the study was to determine the effect of oral N-acetylcysteine (NAC) on levels of serum oxidative stress biomarkers in hemodialysis patients.
METHODS: Forty eight hemodialysis patients were administered NAC orally for six months. Hematological, biochemical parameters and levels of asymmetric dimethylarginine (ADMA), malondialdehyde (MDA), myeloperoxidase (MPO) and nitrogen oxide (NO) were determined prior to and upon completion of the study period.
RESULTS: At the end of the study period white blood cells, neutrophil percentage and C-reactive protein levels were significantly lower. Uric acid, albumin and hemoglobin were significantly higher compared to pre-treatment values. Statistically significant increase in NO, and decrease in MDA and ADMA levels were observed. Serum MPO demonstrated a measurable decrease trend, though not significant.
CONCLUSION: It is suggested that treatment with NAC appears to be associated with restoration of important parameters of antioxidant defence and reduction in the levels of mediators of oxidative cellular damage. Hippokratia 2015; 19 (2):131-135.

Entities:  

Keywords:  N-acetylcysteine; hemodialysis; oxidative stress

Year:  2015        PMID: 27418761      PMCID: PMC4938103     

Source DB:  PubMed          Journal:  Hippokratia        ISSN: 1108-4189            Impact factor:   0.471


  29 in total

Review 1.  Antioxidant therapy in hemodialysis patients: a systematic review.

Authors:  Jeff S Coombes; Robert G Fassett
Journal:  Kidney Int       Date:  2011-10-05       Impact factor: 10.612

2.  Randomized clinical trial on acute effects of i.v. iron sucrose during haemodialysis.

Authors:  Nuria Garcia-Fernandez; Aitziber Echeverria; Alfonso Sanchez-Ibarrola; José Antonio Páramo; Isabel Coma-Canella
Journal:  Nephrology (Carlton)       Date:  2010-03       Impact factor: 2.506

3.  Oxidative stress is progressively enhanced with advancing stages of CKD.

Authors:  Evangelia Dounousi; Eleni Papavasiliou; Areti Makedou; Kyriakos Ioannou; Konstantinos P Katopodis; Alexandros Tselepis; Kostas C Siamopoulos; Dimitrios Tsakiris
Journal:  Am J Kidney Dis       Date:  2006-11       Impact factor: 8.860

4.  Oxidative stress in hemodialysis patients receiving intravenous iron therapy and the role of N-acetylcysteine in preventing oxidative stress.

Authors:  G Swarnalatha; R Ram; Prasad Neela; M U R Naidu; K V Dakshina Murty
Journal:  Saudi J Kidney Dis Transpl       Date:  2010-09

5.  N-acetylcysteine for the management of anemia and oxidative stress in hemodialysis patients.

Authors:  Shih-Ping Hsu; Chih-Kang Chiang; Shao-Yu Yang; Chiang-Ting Chien
Journal:  Nephron Clin Pract       Date:  2010-07-02

6.  The effect of treatment with N-acetylcysteine on the serum levels of C-reactive protein and interleukin-6 in patients on hemodialysis.

Authors:  Fereshteh Saddadi; Sudabeh Alatab; Farahnaz Pasha; Mohammad Reza Ganji; Tayebeh Soleimanian
Journal:  Saudi J Kidney Dis Transpl       Date:  2014-01

7.  Serum uric acid levels show a 'J-shaped' association with all-cause mortality in haemodialysis patients.

Authors:  Shih-Ping Hsu; Mei-Fen Pai; Yu-Sen Peng; Chin-Kang Chiang; Tai-I Ho; Kuan-Yu Hung
Journal:  Nephrol Dial Transplant       Date:  2004-02       Impact factor: 5.992

8.  Plasma F2-isoprostane levels are elevated in chronic hemodialysis patients.

Authors:  T A Ikizler; J D Morrow; L J Roberts; J A Evanson; B Becker; R M Hakim; Y Shyr; J Himmelfarb
Journal:  Clin Nephrol       Date:  2002-09       Impact factor: 0.975

9.  Myeloperoxidase, a leukocyte-derived vascular NO oxidase.

Authors:  Jason P Eiserich; Stephan Baldus; Marie-Luise Brennan; Wenxin Ma; Chunxiang Zhang; Albert Tousson; Laura Castro; Aldons J Lusis; William M Nauseef; C Roger White; Bruce A Freeman
Journal:  Science       Date:  2002-06-28       Impact factor: 47.728

10.  The effects of renal replacement therapy on plasma, asymmetric dimethylarginine, nitric oxide and C-reactive protein levels.

Authors:  Halfize Uzun; Dildar Konukoglu; Mine Besler; Fusun Erdenen; Can Sezgin; Cuneyt Muderrisoglu
Journal:  Clin Invest Med       Date:  2008       Impact factor: 0.825

View more
  1 in total

1.  Effect of a Low Dose of Carvedilol on Cyclophosphamide-Induced Urinary Toxicity in Rats-A Comparison with Mesna.

Authors:  Anna Merwid-Ląd; Piotr Ziółkowski; Marta Szandruk-Bender; Agnieszka Matuszewska; Adam Szeląg; Małgorzata Trocha
Journal:  Pharmaceuticals (Basel)       Date:  2021-11-29
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.